Wong GL - Search Results

1

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.

Zhang X, Zheng MH, Liu D, Lin Y, Song SJ, Chu ES, Liu D, Singh S, Berman M, Lau HC, Gou H, Wong GL, Zhang N, Yuan HY, Loomba R, Wong VW, Yu J. Zhang X, et al. Among authors: wong gl. Cell Metab. 2024 Oct 29:S1550-4131(24)00404-2. doi: 10.1016/j.cmet.2024.10.008. Online ahead of print. Cell Metab. 2024. PMID: 39500327 Free article.

2

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers.

Shen J, Chan HL, Wong GL, Choi PC, Chan AW, Chan HY, Chim AM, Yeung DK, Chan FK, Woo J, Yu J, Chu WC, Wong VW. Shen J, et al. Among authors: wong gl, wong vw. J Hepatol. 2012 Jun;56(6):1363-70. doi: 10.1016/j.jhep.2011.12.025. Epub 2012 Feb 4. J Hepatol. 2012. PMID: 22314419

3

A LEAN treatment for non-alcoholic steatohepatitis.

Wong VW, Wong GL. Wong VW, et al. Among authors: wong gl. Lancet. 2016 Feb 13;387(10019):628-630. doi: 10.1016/S0140-6736(15)00982-4. Epub 2015 Nov 20. Lancet. 2016. PMID: 26608257 No abstract available.

4

Non-alcoholic fatty liver disease in Asia: How is it different from the West?

Wong GL, Wong VW. Wong GL, et al. Among authors: wong vw. J Gastroenterol Hepatol. 2019 Aug;34(8):1267-1268. doi: 10.1111/jgh.14813. J Gastroenterol Hepatol. 2019. PMID: 31456234 No abstract available.

5

Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD.

Tang LJ, Ma HL, Eslam M, Wong GL, Zhu PW, Chen SD, Leeming DJ, Karsdal M, Li G, Huang OY, Leung HH, Zhou YJ, Feng Q, Jiang P, Gao LM, Byrne CD, Targher G, George J, Wong VW, Zheng MH. Tang LJ, et al. Among authors: wong gl, wong vw. Metabolism. 2022 Mar;128:154958. doi: 10.1016/j.metabol.2021.154958. Epub 2021 Dec 24. Metabolism. 2022. PMID: 34958817

6

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Lin H, Zhang X, Li G, Wong GL, Wong VW. Lin H, et al. Among authors: wong gl, wong vw. J Clin Transl Hepatol. 2021 Dec 28;9(6):972-982. doi: 10.14218/JCTH.2021.00201. Epub 2021 Aug 30. J Clin Transl Hepatol. 2021. PMID: 34966660 Free PMC article. Review.

7

N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD.

Tang LJ, Li G, Eslam M, Zhu PW, Chen SD, Leung HH, Huang OY, Wong GL, Zhou YJ, Karsdal M, Leeming DJ, Jiang P, Wang C, Yuan HY, Byrne CD, Targher G, George J, Wong VW, Zheng MH. Tang LJ, et al. Among authors: wong gl, wong vw. Hepatol Int. 2023 Feb;17(1):190-201. doi: 10.1007/s12072-022-10420-w. Epub 2022 Sep 24. Hepatol Int. 2023. PMID: 36152131

8

Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease.

Wang Y, Song SJ, Jiang Y, Lai JC, Wong GL, Wong VW, Yip TC. Wang Y, et al. Among authors: wong gl, wong vw. Clin Mol Hepatol. 2024 Jun 27. doi: 10.3350/cmh.2024.0246. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 38934108 Free article. Review.

9

Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital.

Yan KK, Wong GL, Wong VW, Chan HL. Yan KK, et al. Among authors: wong gl, wong vw. Dig Dis Sci. 2010 Dec;55(12):3541-7. doi: 10.1007/s10620-010-1412-1. Epub 2010 Oct 7. Dig Dis Sci. 2010. PMID: 20927593

10

Fat and fiber: how the controlled attenuation parameter complements noninvasive assessment of liver fibrosis.

Wong GL, Wong VW. Wong GL, et al. Among authors: wong vw. Dig Dis Sci. 2015 Jan;60(1):9-12. doi: 10.1007/s10620-014-3429-3. Epub 2014 Nov 16. Dig Dis Sci. 2015. PMID: 25399331 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters